loadpatents
Patent applications and USPTO patent grants for Mindset Pharma Inc..The latest application filed is for "psilocin derivatives as serotonergic psychedelic agents for the treatment of cns disorders".
Patent | Date |
---|---|
3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of CNS disorders Grant 11,453,689 - Slassi , et al. September 27, 2 | 2022-09-27 |
Psilocin Derivatives As Serotonergic Psychedelic Agents For The Treatment Of Cns Disorders App 20220289774 - Slassi; Abdelmalik ;   et al. | 2022-09-15 |
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders Grant 11,427,604 - Slassi , et al. August 30, 2 | 2022-08-30 |
Psilocin Derivatives As Serotonergic Psychedelic Agents For The Treatment Of Cns Disorders App 20220024956 - Slassi; Abdelmalik ;   et al. | 2022-01-27 |
Psilocin Derivatives As Serotonergic Psychedelic Agents For The Treatment Of Cns Disorders App 20220017549 - Slassi; Abdelmalik ;   et al. | 2022-01-20 |
3-pyrrolidine-indole Derivatives As Serotonergic Psychedelic Agents For The Treatment Of Cns Disorders App 20220017550 - Slassi; Abdelmalik ;   et al. | 2022-01-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.